Utrecht Holdings Utrecht Holdings
  • ‌
  • Academics
  • Companies
  • Funds
  • News
  • About
  • Spin-offs
  • Contact
  • Academics
    • Inventions & Patents
    • Research support
    • Starting a company
    • Policies & Models
    • Valorization Pre-seed
    • Training
  • Companies
    • Spin-offs
    • Licensing Opportunities
  • News
  • About
    • Mission & Vision
    • Knowledge transfer
    • Team
    • Office location
    • Vacancies
  • Spin-offs
  • Contact
    • Directions
Home Cristal Therapeutics

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer

november 1, 2018

Maastricht, The Netherlands, 25th October 2018 – Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient…

  • Utrecht Holdings
    • About
    • Academics
    • Companies
    • Funds
    • Contact
  • Network partners
    • Utrecht Life Sciences
    • Utrecht Science Park
    • Utrecht Sustainability Institute
    • UtrechtInc
    • Utrecht Center of Entrepreneurship
  • Follow us on
    • LinkedIn

Partners and shareholders

© 2023 Utrecht Holdings